Document Detail

Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase.
MedLine Citation:
PMID:  8122189     Owner:  NLM     Status:  MEDLINE    
The dissolution by the fibrinolytic agent saruplase of microthrombi due to disseminated intravascular coagulation (DIC) has been studied in anesthetized rats. The intravenous infusion of E. coli lipopolysaccharide (endotoxin) for 4 hours (total dose: 25 mg/kg) induced marked thrombocytopenia and hypofibrinogenemia. DIC-related microthrombosis, detected as increased deposition of 125I-labelled human fibrin, was found in the liver and the kidneys, but not in the lungs, the heart, the mesenterium, the spleen and the M. rectus abdominis of endotoxemic rats. Treatment with 1-20 micrograms/kg.min saruplase, that was infused concomitantly with endotoxin, dose-dependently and significantly reduced endotoxin-induced microthrombosis in the liver and the kidneys by 85 resp. 88%. When saruplase (20 micrograms/kg.min) was administered only during the last two hours of endotoxin infusion, liver microthrombosis was still significantly dissolved by 69%, whereas renal microthrombosis was insignificantly reduced by 34%. The inhibition of endotoxin-induced microthrombosis took place in the same dosage range as the shortening of the euglobulin clot lysis time in normal rats by saruplase as a measure of its fibrinolytic activity. Saruplase did not modify thrombocytopenia and hypofibrinogenemia in endotoxemic rats. Saruplase per se did not affect plasma fibrinogen levels. Thus, in a fibrin-selective dose range saruplase is able to dissolve microthrombosis associated with DIC in endotoxemic rats.
J Schneider
Related Documents :
15173629 - The organization of the corticonuclear and olivocerebellar climbing fiber projections t...
24660109 - Vitamin c activation of the biosynthesis of epoxyeicosatrienoic acids.
9781719 - Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role...
7167269 - Reevaluation of things past. a test of the "retrospection hypothesis" using a cer proce...
23946349 - Chain length of dietary alkylresorcinols affects their in vivo elimination kinetics in ...
7291229 - Chlorpromazine effects on behavior under escape and fixed-time delivery of shock.
2860609 - Adrenorphin immunoreactivity in rat brain.
3873579 - Objective quantification of tremor in conscious unrestrained rats, exemplified with 5-h...
2853079 - Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis research     Volume:  72     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1994-04-07     Completed Date:  1994-04-07     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  71-82     Citation Subset:  IM    
Grünenthal GmbH, Center of Research, Aachen, FRG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disseminated Intravascular Coagulation / drug therapy*,  etiology
Endotoxins / toxicity
Fibrin / analysis,  drug effects*
Fibrinogen / metabolism,  pharmacokinetics
Organ Specificity
Platelet Count
Rats, Wistar
Recombinant Proteins / therapeutic use
Shock, Septic / complications*
Specific Pathogen-Free Organisms
Thrombolytic Therapy*
Tissue Distribution
Urokinase-Type Plasminogen Activator / therapeutic use*
Reg. No./Substance:
0/Endotoxins; 0/Recombinant Proteins; 67924-63-4/endotoxin, Escherichia coli; 9001-31-4/Fibrin; 9001-32-5/Fibrinogen; 99149-95-8/saruplase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular cloning of cDNA for the bovine urokinase-type plasminogen activator receptor.
Next Document:  Intravascular cysteinyl-leukotriene formation by clotting whole human blood. Evidence from clamped u...